Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Veracyte revenue
Veracyte's revenue is $445.8 million.
What is Veracyte's revenue?
- Veracyte's revenue growth from 2012 to 2024 is 3,733.54%.
- Veracyte has 270 employees, and the revenue per employee ratio is $1,650,977.
- Veracyte's peak quarterly revenue was $118.6M in 2024(q4).
- Veracyte peak revenue was $445.8M in 2024.
- Veracyte annual revenue for 2023 was 361.1M, 21.76% growth from 2022.
- Veracyte annual revenue for 2024 was 445.8M, 23.46% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Veracyte historical revenue
Veracyte's peak revenue was $445.8M in 2024. The peak quarterly revenue was $118.6M in 2024(q4).
Veracyte's revenue increased from $11.6m in 2012 to $445.8M currently. That's a 3,733.54% change in annual revenue.
Veracyte annual revenue
Veracyte annual revenue over time
| Fiscal year / year | Veracyte revenue |
|---|---|
| 2012 | $11.6M |
| 2013 | $21.9M |
| 2014 | $38.2M |
| 2015 | $49.5M |
| 2016 | $65.1M |
| 2017 | $72.0M |
| 2018 | $92.0M |
| 2019 | $120.4M |
| 2020 | $117.5M |
| 2021 | $219.5M |
| 2022 | $296.5M |
| 2023 | $361.1M |
| 2024 | $445.8M |
Rate Veracyte's financial transparency
Veracyte annual growth
Veracyte saw the greatest revenue growth in 2013, when revenue increased by 88.2%.
Veracyte had the lowest revenue growth in 2020, when revenue changed by -2.4%.
Veracyte annual growth rate over time
| Year | Veracyte growth |
|---|---|
| 2013 | 88%↑ |
| 2014 | 75%↑ |
| 2015 | 30%↑ |
| 2016 | 31%↑ |
| 2017 | 11%↑ |
| 2018 | 28%↑ |
| 2019 | 31%↑ |
| 2020 | -2%↓ |
| 2021 | 87%↑ |
| 2022 | 35%↑ |
| 2023 | 22%↑ |
| 2024 | 23%↑ |
Veracyte quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Veracyte quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2013 | - | - | $5.6M | $6.8M |
| 2014 | $7.5M | $8.7M | $9.8M | $12.2M |
| 2015 | $11.2M | $11.9M | $12.3M | $14.0M |
| 2016 | $13.6M | $14.7M | $18.6M | $18.3M |
| 2017 | $16.4M | $18.4M | $17.5M | $19.6M |
| 2018 | $20.0M | $22.8M | $23.5M | $25.8M |
| 2019 | $29.5M | $30.1M | $31.0M | $29.7M |
| 2020 | $31.1M | $20.7M | $31.1M | $34.5M |
| 2021 | $36.7M | $55.1M | $60.4M | $67.3M |
| 2022 | $67.8M | $72.9M | $75.6M | $80.3M |
| 2023 | $82.4M | $90.3M | $90.1M | $98.2M |
| 2024 | $96.8M | $114.4M | $115.9M | $118.6M |
Veracyte jobs nearby
Do you work at Veracyte?
Did Veracyte meet its revenue projections?
Veracyte financial information
| CEO | Marc A. Stapley |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 270 |
| Date Founded | 2006 |
| Headquarters | South San Francisco, California |
| Number of Locations | 4 |
| Revenue | $445.8M |
| Net Income | -$36,560,000 |
| Gross Proft | $298.1M (2024) |
| PE Ratio | 58.93 |
| Tax Rate | 0.1% |
| Market Capitalization | $1.4B |
| Total Assets | $1,156,422,000 |
| Ticker | VCYT |
Veracyte jobs you might like
Veracyte financing
Veracyte received early financing of $300.0K on 2006-12-21.
| Series | Round size | Date |
|---|---|---|
| Series A | $300K | 12/2006 |
| Series B | $28M | 06/2010 |
| Private Equity | $15.0M | 10/2012 |
| Series C | $28M | 06/2013 |
| Debt Financing | $15M | 01/2014 |
| Post Ipo Debt | $45M | 03/2016 |
| Post Ipo Equity | $550M | 02/2021 |
Veracyte investors
| Investors | Security type |
|---|---|
| Versant Ventures | Series B |
| TPG Biotech | Series B |
| Kleiner Perkins | Series B |
| Domain Associates | Series B |
| Kleiner Perkins | Private Equity |
| Domain Associates | Private Equity |
| Versant Ventures | Series C |
| GE Ventures | Series C |
| Kleiner Perkins | Series C |
| TPG Biotech | Series C |
| Domain Associates | Series C |
| Armentum Partners | Debt Financing |
| Visium Healthcare Partners | Post Ipo Debt |
Veracyte competitors
Veracyte's top competitor, Illumina, earned an annual revenue of $4.4B.
Veracyte's smallest competitor is Geneoscopy with revenue of $430.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| MDxHealth | - | $5.9M | 171 | - |
| Geneoscopy | - | $430,000 | 29 | - |
| Illumina | - | $4.4B | 7,800 | - |
| Ambry Genetics | - | $96.0M | 94 | - |
| Admera Health | - | $1.0M | 75 | - |
| Guardant Health | - | $739.0M | 500 | - |
| Institute for Systems Biology | - | $37.5M | 230 | - |
| 454 Life Sciences | - | $19.4M | 100 | - |
| Foundation Medicine | - | $152.9M | 1,300 | - |
| Life Tech International | - | $620,000 | 25 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Veracyte highest paying jobs
Zippia gives an in-depth look into the details of Veracyte, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Veracyte. The employee data is based on information from people who have self-reported their past or current employments at Veracyte. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Veracyte. The data presented on this page does not represent the view of Veracyte and its employees or that of Zippia.
Veracyte may also be known as or be related to VERACYTE INC., VERACYTE, INC., Veracyte, Veracyte Inc and Veracyte, Inc.